{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:47:00Z","timestamp":1777492020073,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:00:00Z","timestamp":1601164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:00:00Z","timestamp":1601164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK062708"],"award-info":[{"award-number":["T32DK062708"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10620-020-06618-3","type":"journal-article","created":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T13:02:21Z","timestamp":1601211741000},"page":"3192-3198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0157-6066","authenticated-orcid":false,"given":"Vincent L.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Hawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Berinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanakyaram A.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin D.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calen A.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Louissaint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh T.","family":"Gunaratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,27]]},"reference":[{"key":"6618_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533\u2013534.","journal-title":"Lancet Infect Dis"},{"key":"6618_CR2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.14309\/ajg.0000000000000620","volume":"115","author":"L Pan","year":"2020","unstructured":"Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115:766\u2013773.","journal-title":"Am J Gastroenterol"},{"key":"6618_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang F-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428\u2013430.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"6618_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.013","author":"AM Moon","year":"2020","unstructured":"Moon AM, Webb GJ, Aloman C, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.013","journal-title":"J Hepatol"},{"key":"6618_CR5","doi-asserted-by":"publisher","first-page":"e0173499","DOI":"10.1371\/journal.pone.0173499","volume":"12","author":"MH Le","year":"2017","unstructured":"Le MH, Devaki P, Ha NB, et al. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS ONE. 2017;12:e0173499.","journal-title":"PLoS ONE"},{"key":"6618_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","volume":"47","author":"Y Eguchi","year":"2012","unstructured":"Eguchi Y, Hyogo H, Ono M, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol. 2012;47:586\u2013595.","journal-title":"J Gastroenterol"},{"key":"6618_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/aje\/kws448","volume":"178","author":"M Lazo","year":"2013","unstructured":"Lazo M, Hernaez R, Eberhardt MS, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994. Am J Epidemiol. 2013;178:38\u201345.","journal-title":"Am J Epidemiol"},{"key":"6618_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124\u2013131.","journal-title":"Gastroenterology"},{"key":"6618_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3319","author":"W Guo","year":"2020","unstructured":"Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020. https:\/\/doi.org\/10.1002\/dmrr.3319.","journal-title":"Diabetes Metab Res Rev"},{"key":"6618_CR10","first-page":"1392","volume":"43","author":"C Qingxian","year":"2020","unstructured":"Qingxian C, Fengjuan C, Fang L, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Lancet Infect Dis. 2020;43:1392\u20131398.","journal-title":"Lancet Infect Dis"},{"key":"6618_CR11","first-page":"3","volume":"1","author":"D Ji","year":"2020","unstructured":"Ji D, Qin E, Xu J, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;1:3.","journal-title":"J Hepatol"},{"key":"6618_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112:18\u201335.","journal-title":"Am J Gastroenterol"},{"key":"6618_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261\u2013283.","journal-title":"Hepatology"},{"key":"6618_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503\u2013508.","journal-title":"Dig Liver Dis"},{"key":"6618_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15112","author":"F Gao","year":"2020","unstructured":"Gao F, Zheng KI, Wang XB, et al. Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients. J Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1111\/jgh.15112.","journal-title":"J Gastroenterol Hepatol"},{"key":"6618_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321611","author":"G Targher","year":"2020","unstructured":"Targher G, Mantovani A, Byrne CD, et al. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. Gut. 2020. https:\/\/doi.org\/10.1136\/gutjnl-2020-321611.","journal-title":"Gut"},{"key":"6618_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S2468-1253(20)30084-4","volume":"5","author":"MN Bangash","year":"2020","unstructured":"Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5:529\u2013530.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"6618_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/apt.15916","volume":"52","author":"AV Kulkarni","year":"2020","unstructured":"Kulkarni AV, Kumar P, Tevethia HV, et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584\u2013599.","journal-title":"Aliment Pharmacol Ther"},{"key":"6618_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10072-8","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Choudhury A, Lau GK, et al. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020. https:\/\/doi.org\/10.1007\/s12072-020-10072-8.","journal-title":"Hepatol Int"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06618-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T23:59:04Z","timestamp":1632700744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06618-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,27]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["6618"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06618-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,27]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Vincent Chen, Fadi Hawa, Jeffrey Berinstein, Chanakyaram Reddy, Ihab Kassab, Kevin Platt, Chia-Yang Hsu, Jeremy Louissaint, Calen Steiner, and Pratima Sharma: no financial conflicts of interest to disclose. Naresh Gunaratnam: Co-founder and CMO, Lean Medical, LL. Speaker, Nestle Health Services.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}